Emergent BioSolutions (EBS) EBIT (2011 - 2026)
Emergent BioSolutions' EBIT was -$125.1 million in Q2 2026, compared with $1.6 million a year earlier.
Powered by 
Analysis
Emergent BioSolutions (EBS) EBIT (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Emergent BioSolutions' EBIT was -$66 million through Jun 30, 2026; for FY2025, it came in at $100.1 million.
- EBIT shows a five-year compound annual growth rate of -25.6% (FY2020 to FY2025).
- In earlier years, EBIT was -$108.7 million in FY2024, -$726.4 million in FY2023, -$170 million in FY2022 and $341.4 million in FY2021 (-22.1%).
- The Q2 2026 figure marks the lowest quarterly EBIT since Q2 2024.
- Per Business Quant data, EBS's EBIT in the three quarters before Q2 2026 was $10.5 million (Q1 2026), -$27.9 million (Q4 2025) and $76.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.90 Bn | 1,105.48 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 617.06 Bn | 535.59 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 501.38 Bn | 474.49 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.92 Bn | 261.91 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.31 Bn | 235.00 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 236.29 Bn | 191.69 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 190.40 Bn | 164.60 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 169.55 Bn | 116.19 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Emergent BioSolutions | 325.34 Mn | -425.56 Mn | 137.20 Mn | -125.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -125.10 Mn |
| Mar 31, 2026 | 10.50 Mn |
| Dec 31, 2025 | -27.90 Mn |
| Sep 30, 2025 | 76.50 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 49.90 Mn |
| Dec 31, 2024 | -9.50 Mn |
| Sep 30, 2024 | 64.50 Mn |
| Jun 30, 2024 | -203.50 Mn |
| Mar 31, 2024 | 39.80 Mn |
| Dec 31, 2023 | -43.80 Mn |
| Sep 30, 2023 | -242.10 Mn |
| Jun 30, 2023 | -292.90 Mn |
| Mar 31, 2023 | -147.60 Mn |
| Dec 31, 2022 | -55.30 Mn |
| Sep 30, 2022 | -45.30 Mn |
| Jun 30, 2022 | -76.30 Mn |
| Mar 31, 2022 | 6.90 Mn |
| Dec 31, 2021 | 286.80 Mn |
| Sep 30, 2021 | -44.70 Mn |
API Access
Emergent BioSolutions EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();